Interpace Diag Group (IDXG)

$0.98 +0.01 (1.03%)
Market Cap 4.29M
Revenue (ttm) 46.93M
Net Income (ttm) 6.70M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 14.28%
Debt to Equity Ratio 0.00
Volume 21,200
Avg Vol 7,996
Day's Range N/A - N/A
Shares Out 4.42M
Stochastic %K 39%
Beta 0.88
Analysts Strong Buy
Price Target $11.00

Company Profile

Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test for the diagnosis of pancreaticobiliary cancers using its proprietary PathFinderTG platform; PanDNA, a molecular only version of PancraGEN; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. The company also provides ThyraMIR v2...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 855 776 6419
Address:
Waterview Plaza, Suite 310 2001 Route 46, Parsippany, United States
Esau815
Esau815 Nov. 13 at 1:36 PM
$IDXG Agreed. More than respectable quarter. Believe that the plan is to be DONE with the debt by year end. Almost miraculoulous that they were able to stall PancraGen's demise by 18 months to get that debt paid off AND to heave Preferred's convert. Let's see if they can sell this as a debt free company with $35MM in revenues and positive EBITDA. Elimination of interest and debt outstanding will immensely help with cash flow going into 2026.
0 · Reply
Waters59
Waters59 Nov. 12 at 9:39 PM
$IDXG The results were actuall good considering this is the first full quarter of the Company being a Thyroid-only diagnostics testing company. https://www.interpace.com/news-media/press-releases/detail/245/interpace-biosciences-announces-third-quarter-2025
0 · Reply
apppro
apppro Nov. 12 at 9:18 PM
$IDXG OK they just reported. OK not out of business, but not good either.
0 · Reply
Waters59
Waters59 Nov. 12 at 2:46 PM
$IDXG Let's Go! 🚀
0 · Reply
apppro
apppro Nov. 10 at 4:44 PM
$IDXG when do these idiots report?? I have on calender today but who the F knows anymore
0 · Reply
Waters59
Waters59 Nov. 10 at 4:38 PM
$IDXG
0 · Reply
Waters59
Waters59 Nov. 3 at 8:00 PM
$IDXG Don't let this go back down. Chug-a-lug! 🚀
0 · Reply
Waters59
Waters59 Oct. 31 at 3:01 PM
$IDXG Eat those shares! Gobble gobble. Let's Go! 🚀
0 · Reply
crane_train21
crane_train21 Oct. 30 at 11:00 PM
$IDXG I dumped shares and it bumped immediately lmao
1 · Reply
Waters59
Waters59 Oct. 30 at 11:59 AM
$IDXG Let's go baby! 🚀 🚀
0 · Reply
Latest News on IDXG
No data available.
Esau815
Esau815 Nov. 13 at 1:36 PM
$IDXG Agreed. More than respectable quarter. Believe that the plan is to be DONE with the debt by year end. Almost miraculoulous that they were able to stall PancraGen's demise by 18 months to get that debt paid off AND to heave Preferred's convert. Let's see if they can sell this as a debt free company with $35MM in revenues and positive EBITDA. Elimination of interest and debt outstanding will immensely help with cash flow going into 2026.
0 · Reply
Waters59
Waters59 Nov. 12 at 9:39 PM
$IDXG The results were actuall good considering this is the first full quarter of the Company being a Thyroid-only diagnostics testing company. https://www.interpace.com/news-media/press-releases/detail/245/interpace-biosciences-announces-third-quarter-2025
0 · Reply
apppro
apppro Nov. 12 at 9:18 PM
$IDXG OK they just reported. OK not out of business, but not good either.
0 · Reply
Waters59
Waters59 Nov. 12 at 2:46 PM
$IDXG Let's Go! 🚀
0 · Reply
apppro
apppro Nov. 10 at 4:44 PM
$IDXG when do these idiots report?? I have on calender today but who the F knows anymore
0 · Reply
Waters59
Waters59 Nov. 10 at 4:38 PM
$IDXG
0 · Reply
Waters59
Waters59 Nov. 3 at 8:00 PM
$IDXG Don't let this go back down. Chug-a-lug! 🚀
0 · Reply
Waters59
Waters59 Oct. 31 at 3:01 PM
$IDXG Eat those shares! Gobble gobble. Let's Go! 🚀
0 · Reply
crane_train21
crane_train21 Oct. 30 at 11:00 PM
$IDXG I dumped shares and it bumped immediately lmao
1 · Reply
Waters59
Waters59 Oct. 30 at 11:59 AM
$IDXG Let's go baby! 🚀 🚀
0 · Reply
Waters59
Waters59 Oct. 29 at 12:55 PM
$IDXG Yes! Gobble up those shares! 🚀 Let's go!
0 · Reply
Waters59
Waters59 Oct. 28 at 2:38 PM
$IDXG Let's go! Gobble up thos shares! 🚀 lol
0 · Reply
Waters59
Waters59 Oct. 27 at 12:12 PM
$IDXG Gobble up those shares! Let's break $1! 🚀
0 · Reply
Waters59
Waters59 Oct. 13 at 11:54 AM
$IDXG Break that wall! Let's Go!
0 · Reply
Waters59
Waters59 Oct. 1 at 4:15 PM
$IDXG climb that ladder
0 · Reply
Waters59
Waters59 Sep. 26 at 1:59 PM
$IDXG About time this does something....
0 · Reply
Waters59
Waters59 Sep. 24 at 2:34 PM
$IDXG Sell the company already!
0 · Reply
Cujo
Cujo Sep. 3 at 2:22 AM
$IDXG
1 · Reply
Waters59
Waters59 Aug. 28 at 4:29 PM
$IDXG So many years, it's just numb. 😆 Sell the Company already!
0 · Reply
Waters59
Waters59 Aug. 21 at 2:37 PM
$IDXG
0 · Reply
Esau815
Esau815 Aug. 8 at 2:25 AM
$IDXG Very respectable quarter given the PancraGen overhang. Revenues are within 80% of what they were when PancraGen was around. Cash flow positive and cash flow will dramatically increase after the October 1 debt is extinguished. The PancraGen delay undoubtedly saved the company in that PE gave up their preference and a good chunk of the (then) $12MM debt got paid while it was around. Waiting for the Q. But with $3.3MM disclosed in July? We're talking revenues of close to $40MM without Pancragen. At 1.5 times revenues? That's about $60MM. 27MM shares. That's a bit over $2. I think that's we're sold and that's where I think we're going.
0 · Reply
apppro
apppro Aug. 7 at 8:10 PM
$IDXG
0 · Reply